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ABSRACT 
 
Hypertension is one of the major independent risk factor for cardiovascular diseases. 
Angiotensin converting enzyme (ACE) plays an important role in regulation of blood 
pressure as well as cardiovascular function. It converts angiotensin I into angiotensin II in  
blood, which  causes the muscles surrounding blood vessels to contract and narrow the 
vessels thus increasing the pressure within the blood vessels and may lead to hypertension. 
ACE was also reported to inactivate bradykinin, a vasodilator. ACE inhibitors have 
achieved widespread usage in the treatment of cardiovascular and renal diseases mainly in 
the treatment of hypertension. In the present study, bacteria isolated from OMFED curd 
were utilized to produce anti-hypertensive peptides from milk. The peptides were used for 
the development of a novel physiologically functional food, watermelon ravioli, having 
anti-hypertensive property. ACE cleaves hippuryl -L-histidyl-L-leucine (HHL) into hippuric 
acid (HA) and histidyl leucine (HL). Production of anti-hypertensive peptides was evaluated 
by direct spectrophotometric determination of HA. The extent of HA released is directly 
propotional to ACE activity. The amount of HA was determined by using HA standard 
graph.  Inhibitory activity of the anti-hypertensive peptides produced by fermentation of 
milk in presencce of the isolated bacteria, was compared to a known inhibitor of ACE 
(captopril).   
 Key words: Angiotensin converting enzyme (ACE), ACE inhibitor, Hippuryl-L-histidyl-
L-leucine, hippuric acid, antihypertensive peptide. 
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INTRODUCTION 
Probiotics are living organisms defined as a viable microbial dietary supplement which has a 
beneficial effect on the host through intestinal tract. It has also been proposed to be “a live 
microbial food ingredient that is beneficial to health” [Salminen et. al., 1998]. These are both 
gram positive & gram negative which are used in constipation  & colities, play an important 
role in immunological modulation, respiratory , gastrointestinal function , alleviation of 
diarrhoea, improvement of irritable bowel, lactose intolerance, antimicrobial properties , etc. 
[Floch et. al., 2011] .  It gives protection by competing with intestinal pathogens through the 
release of bacteriocin, an antibacterial substance [Cotter et. al., 2005], also some metabolites 
like lactic acid and acetic acid [Servin, 2004]. The main action of probiotic is reinforcement 
of the intestinal mucosal barrier against various agents. It reduce pathological alteration in 
paracellular permeability to large molecules & also mucosal immunity is stimulated, reduce 
mucus degradation & interact with mediators of inflammation [Jean et. al., 2003]. The most 
common probiotic bacteria are Lactobacillus and Bifidobacterium used for the production of 
food like yogurt, cheese, pickle etc. However, recent studies have suggested that probiotics 
could have beneficial effects beyond gastrointestinal health, as they were found to improve 
certain metabolic disorders such as hypertension. Hypertension is caused by various factors 
and the predominant causes include an increase in cholesterol levels, incidence of diabetes, 
inconsistent modulation of renin and imbalanced sexual hormones. Cardiovascular diseases 
like coronary heart disease, atherosclerosis, stroke, and heart failure are a major health 
concern, because they are one of the leading causes of death. The major risk factor of 
cardiovascular diseases is hypertension [Chrysant et al., 2013] which is estimated to be 
affecting about 20% of world’s population (Jordan et al., 2001). Hypertension is defined by 
the World Health Organisation (WHO) as the exceeding of 90 mmHg for the diastolic arterial 
pressure, and 140 mmHg for the systolic pressure. Angiotensin I-converting enzyme (ACE, 
dipeptidyl carboxypeptidase, EC 3.4.15.1) plays an important role in the regulation of blood 
pressure as well as cardiovascular function. ACE converts the inactive decapeptide 
angiotensin I into the potent vaso-constricting octapeptide angiotensin II and also inactivates 
vasodilator, bradykinin (Na et al., 2000). Inhibition of ACE is considered to be a useful 
therapeutic approach in the treatment of hypertension. Therefore, in the development of drugs 
to control high blood pressure, ACE inhibition has become an important activity. Many 
studies have been attempted in the synthesis of ACE inhibitors such as captopril, enalapril, 
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alcacepril and lisinopril, which are currently used in the treatment of essential hypertension 
and heart failure in humans (Schmidt et al 2014,). However, these synthetic drugs are 
believed to have certain side effects such as cough, taste disturbances, skin rashes or 
angioneurotic edema all of which might be intrinsically linked to synthetic ACE inhibitors 
(Atkinson and Robertson, 1979). Therefore, the research and development to find safer, 
innovative, and economical ACE inhibitors is necessary for the prevention and remedy of 
hypertension [Anne et al., 2011]. Many research groups have combed for novel ACE 
inhibitors from natural products [Gasse et al., 1984], microbial sources and food proteins. 
Functional foods, beneficial to health, are having a marked effect on the food sector. The 
production of functional foods has paid special attention to the study of the physiological role 
played by dietary proteins. There are certain fragments within the sequence of food proteins 
that may show biological activity once released by hydrolysis. These fragments, known as 
bioactive peptides, can be produced in vivo by the action of gastrointestinal enzymes and can 
also be obtained in vitro using specific enzymes, or during the fermentation of certain foods. 
In the present study we are focusing on development of watermelon raviolis, a functional 
food consisting of anti-hypertensive peptides by the process of encapsulation. Here we 
developed the beads of milk fermented with the proteolytic isolates which were again 
encapsulated along with fruit juice (watermelon) and honey. As we know the survival of 
bacteria inside the upper gastrointestinal tract is poor due to the acidic and enzymatic 
secretions, hence in order to provide protection against several environmental factors inside 
GIT encapsulation method is adopted. By creating a microenvironment where the bacteria 
will survive during processing and storage while being released to particular site in the 
intestine.  
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REVIEW OF LITERATURE 
Probiotics are usually defined as living microbial dietary adjuvants, which has a beneficial 
effect on human physiology by improving nutritional and microbial balance in the intestinal 
tract [Fuller, 1989; Guarner and Schaafsma, 1998]. After birth these microbial flora 
inhabitate the human intestinal tract. About 400 species of various commensal 
microorganisms whether bacteria, viruses, yeast lived in the digestive tract [Moore and 
Holdeman, 1974; Koop-Hoolihan, 2001]. The grandfather of modern probiotic Eli 
Metchnikoff discovered that the lactic acid bacteria (LAB) can have a positive influence on 
digestion and the immune system [Anukam and Reid, 2008]. Probiotic microorganisms may 
be gram-positive (Lactobacillus) or gram- negative (Escheria coli) and are used in the 
treatment of intestinal dysfunction [Marco, Pavan and Kleerebezem, 2006]  and  treatment of 
chronic constipation  [Mollenbrink and Bruckschen, 1994] and colitis. Probiotics are 
beneficial components that have been used to modulate gastrointestinal health like improving 
lactose intolerance, increasing infection resistance, suppression of pathogenic bacteria etc. 
Currently the most important applications of probiotics involve benefits like anti-
hypertension, immuno-modulation, improving serum lipid profiles & alleviation of post 
menopausal disorder. 
                        For the evaluation of health and nutritional properties of probiotics, first of all 
these should not posses pathogenic character, not capable of transferring antibiotic resistance 
to pathogen, then it also should not be the source of antibiotic resistance [Joint FAO/WHO 
Expert consultation on evaluation of health and nutritional properties of probiotics in Food 
including power milk with live lactic acid bacteria. Probiotic like Lactic acid bacteria 
produces a range of short chain fatty acid like acetic, lactic, butyric and propionic acid during 
fermentation, which reduces the intestinal milieu pH and has inhibitory effect against 
pathogenic bacteria. Normally Lactic acid & acetic acid inhibit the growth of pathogen like 
Staphylococcus aureus, Salmonella typhimurium, Campylobacter shigella etc. Hydrogen 
peroxide, produced by Lactic acid bacteria, controls the growth of Candida albicans.  
                 About 70% of world’s population have low amount of beta-galactosidase leading 
to lactose intolerance where lactose behaves like osmotic, non-digestible carbohydrate. 
Probiotics are used to improve lactose digestion by producing beta-galactosidase enzyme 
thereby reducing the intolerance & also slowing oro-cecal transit [Sanders, 1993]. These 
5 
 
bacteria play an important role in functioning of mucosal immune system.  In case of infants 
for the enhancement of immunoglobulin-A, Lactobacillus casei strain are supplemented. The 
major habitat for probiotic bacteria is intestinal mucosa, so they closely associate with gut 
associated lymphoid tissue (GALT), because it constitutes largest lymphoid tissue in human 
body. 
             Another application of Probiotic bacteria is the reduction of serum lipid level. By 
several mechanisms LAB can reduce the cholesterol and lipid level such as direct 
assimilation of cholesterol, deconjugation of bile salts and reduced transport of cholesterol to 
plaque deposits and inhibit the formation of low density lipoprotein [Fuller R., 1989]. When 
beta-hydroxyl-beta-methyl-glutaril- coenzyme A reductase is consumed with probiotic in 
liver, it will decrease the cholesterol synthesis. Probiotic help in balancing the intestinal flora 
thus reduce the risk of diarrhoea, stress, antibiotic effects, Candida infection and food 
allergy. These strains are also used for urogenital therapy by attaching them to vaginal and 
uro-epithelial cells as they are able to interfere with adhesion of pathogens. 
          Most of fermented dairy products or dietary supplements, such as yogurt and kefir 
contain probiotic organisms [Salminen, Isolauri and Salminen, 1996] such as Lactobacillus, 
Bifidobacterium, Streptococcus thermophiles and Bacillus spp. Yogurt, the primary food 
containing probiotics, is produced by fermentation of milk using 2 starter cultures, 
Lactobacillus bulgaricus & Streptococcus thermophilus . 
                         Milk, an excellent source of proteins and peptides, exhibit a range of 
biological activities influencing digestion. The specific functions of milk include supply of 
amino acids, nitrogen and proteins which provide protection, micelle formation and facilitate 
the uptake of several necessary nutrients such as trace elements and vitamins. Milk proteins 
are highly functional due to presence of biologically active peptides having anti-hypertensive, 
cyto-modulatory, hypo-cholesterolemic, anti-oxidative, anti-thrombotic, immuno-stimulating, 
anti-microbial, mineral carrying and cholesterol lowering activity [Shah, 2000]. By 
proteolytic hydrolysis or enzymatic digestion, many bioactive peptides are produced from 
milk [Kamau et.al, 2010]. The type & density of peptides released depend upon the quantity 
and quality of milk, presence of additional food, pH and enzymatic action. The Fermented 
milk products have high nutritional value, which will give rise to many health-promoting 
effects, like improvement of lactose metabolism, serum cholesterol level reduction and 
decrease the risk of cancer [Shah, 2007]. LAB can hydrolyze casein protein into peptides and 
amino acids during normal fermentation process. Bioactive peptides are produced by both 
starter and non-starter bacteria like Lb. helveticus, Lb. delbrueckii ssp bulgaricus, L. lactis 
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ssp. diacetylactis, L. lactis ssp. cremoris and Streptococcus (Str.) salivarius ssp. thermophilus 
which are used to hydrolyze milk proteins and release ACEI (Angiotensin converting enzyme 
inhibitor) peptides. The bacterial cell consists of cell wall-bound proteinase and a number of 
distinct intracellular peptidases, endopeptidases, aminopeptidases, tripeptidases and 
dipeptidases [Christensen et.al, 1999]. One of the bacterial strains of Lb. helveticus produces 
oligo-peptides by the digestion of milk proteins [Foucaud and Juillard, 2000] which is known 
to have high proteolytic activities [Luoma et.al, 2001]. The activities of peptidases depend 
upon the growth conditions which makes it possible for the formation of peptides [Williams 
et.al, 2002].  
                    Bioactive peptides, specific protein fragments having positive impact on body 
functions and conditions, may ultimately influence health [Fitzgerald and Murray, 2006]. 
Bioactive peptides may affect major body systems like cardiovascular, digestive, immune and 
nervous system. These beneficial health effects are anti-microbial, anti-oxidative, anti-
hypertensive and immuno-modulatory [Fitz and Meisei, 2003]. 
                  The liberated bioactive peptides may act as regulatory compounds like hormones. 
There are numerous peptides isolated, which exhibit various activities such as opiate, anti-
thrombotic or anti-hypertensive activity, immune-modulation or mineral utilization properties 
etc. Though other animal as well as plant proteins also contain bioactive peptide sequences 
but milk proteins are the important source for the production of bioactive peptides. The first 
biologically active peptides found in milk were opioid peptides and immuno-modulatory 
peptides. Opioid peptides in dairy products have an important role in nervous system 
[Teschemacher, 1997]. They are short sequences of amino acids which mimic the effect of 
opiate in the brain. Brain opioid peptide system play specific role in motivation, emotion, 
stress, pain and also control the food intake [Nakamura et.al, 1995]. The potency of 
bioactivity of peptides is inversely related to chain length. Angiotensin II can affect bone by 
decreasing the osteoplast differentiation and increasing osteoclastic bone resorption. So for 
the formation of bone, ACE inhibition is required which increases the vascular endothelial 
growth factor formation [Hiruma et al., 1998; Hatton et al., 1997]. ACE inhibition can also 
multiply the activity of bradykinin which has a specific role in bone formation. Immuno-
modulatory peptides help in proliferation of lymphocytes, phagocytic activities of 
macrophages and antibody synthesis. These peptides also help in proliferation and maturation 
of T-cells and natural killer cells for defence mechanism against enteric bacteria [Clare and 
Swaisgood, 2000].  Also immune-modulatory milk peptides alleviate the allergic reaction and 
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increase the mucosal immunity in digestive tract which regulates the growth of immune 
system in infants.  
There are two well-known peptides isolated from sour milk which have ACE 
inhibitory activity, val-pro-pro (VPP) and ile-pro-pro (IPP) derived from casein. Whey 
protein derived peptides may also show ACE inhibition. The ACE inhibitory peptides have 
C-terminal amino acid sequence which is hydrophobic and can compete with substrate as the 
side chains of these amino acids interact with the active site of ACE. For ACE inhibition C-
terminal tryptophan, proline, tyrosine and phenylalanine are the most effective amino acid 
residues. Immuno-modulating peptides are detected in human and cow milk proteins 
[Migliore-Samour and Jolls, 1988]. A group of peptides shows the inhibition of ACE in 
favour of formation of bradykinin, acting as immuno-modulator [Pagelow and Werner, 
1986]. Casein derived peptides have very interesting applications in dietary supplements and 
pharmaceutical preparations such as tablets, toothpaste etc.   
 
Antihypertensive peptides: 
Hypertension is a multifactor disorder that is caused by an interaction between environmental 
factors and genetic background.  As there are various type of anti-hypertensive drugs 
discovered [Arsenault et.al, 2010], lacto-tripeptides have an inhibitory activity against ACE. 
Several studies have suggested that ACE activity is not affected by the oral tri-peptide 
administration so other mechanisms are needed to be applied for the reduction of blood 
pressure. As we know cardiovascular disease (CVD) is one of the leading and targeting 
diseases in world causing death of both males and females. So far, for the reduction of CVD 
risk on human health, improved diet and lifestyle has been adopted. The most independent 
risk factor for CVD is hypertension and Angiotensin I-converting enzyme (ACE) plays an 
important role in blood pressure controlling by converting angiotensin I into angiotensin II (a 
vasoconstrictor) and it also inactivates bradykinin (a vasodilator) [Harris et al.,1985]. Various 
synthetic ACE inhibitors like captopril, enalapril, lisinopril, and ramipril have been widely 
used in the clinical treatment of hypertension and heart failure in humans. But these synthetic 
ACE inhibitors can have side effects including cough, taste disturbances and skin rashes 
[Messerli and Hypertens, 1999]. So the natural ACE inhibitors are inevitable to rule out 
further complications. The antihypertensive peptides in fermented food products are reported 
to be very effective natural ACE inhibitors. Many ACE inhibitory peptides have been 
reported to be formed by enzymatic hydrolysis of natural food protein like casein, whey 
protein fish protein soy bean protein and corn gluten. The primary source of antihypertensive 
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peptides is dairy products like cheese and yogurt. Sour milk fermented with Lb. helveticus 
contains lacto-tripeptides, IPP and VPP, well known ACE inhibitors.  The amount of IPP and 
VPP increases during the cheese ripening process. Whey protein produces an anti-
hypertensive dipeptide Tyr-pro. From the parent protein peptides are delivered either by 
enzymatic hydrolysis during gastrointestinal digestion, fermentation with proteolytic starter 
cultures or hydrolysis by enzymes obtained from micro-organisms. If the structure of these 
peptides is known, it is also possible to synthesize peptides by chemical synthesis, 
recombinant DNA technology or enzymatic synthesis. When the isoelectric casein is 
hydrolysed with pepsin it generates anti-hypertensive peptides, some of the potent ACE-
inhibitory peptides other than the two tripeptides are RYLGY, AYFYPEL and YQKFPQY, 
which have in vitro radical scavenging activity and anti-hypertensive activity. These peptide 
sequences are resistant to gastrointestinal enzymatic activity. Thus in our body blood pressure 
is partially controlled by renin angiotensin system (RAS).  
ACE is a multifunctional ecto-enzyme. It is a bivalent dipeptidyl carboxyl metallo-peptidase 
which is present in the membrane-bound form in endothelial, epithelial or neuro-epithelial 
cells [Skidgel and Erdos, 1993], located in different tissues. The increase and decrease in 
blood pressure conditions is especially dependent on ACE activity. The greater the ACE 
activity, the more angiotensin I is converted to angiotensin II, which induces high blood 
pressure. ACE converts angiotensin I into angiotensin II by removing the C-terminal 
dipeptide HL, rennin act on angiotensinogen which is an inactive precursor. ACE also breaks 
down the bradykinin which is a vasodilator. Smooth muscle has AT1 receptors coupled with    
Gq  protein, bind to arteries and veins which are constricted by Angiotensin II. Angiotensin II 
facilitates the release of norepinephrine from adrenergic nerves and inhibits the reuptake of 
norepinephrine.Fig-1 shows the mechanism of ACE activity.  
Hence inhibition of ACE results in lowering hypertension. ACE inhibitor  are help in  dilating  
arteries and veins by inhibiting the metabolism of bradykinin. Vasodilation reduces the 
arterial blood pressure. It also down regulates the sympathetic adrenergic activity  with the 
blockage of  angiotensin II . 
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                                            Fig-1: Mechanism of ACE activity 
 
 
ACEI  have natriuretic and diuretic effects, can also promote renal excretion of sodium and 
water by blocking the effects of angiotensin II on kidney and aldosterone secretion. Therefore 
ACE inhibition gives rise to hypotensive effect that influences the immune-defence and 
nervous system activity. These peptides are showing the antihypertensive effect after 2-8 
hour of administration. Studies show that the anti-hypertensive effect of dose dependent 
peptide in spontaneous hypertensive rats was from 0.2-2 mg/kg of body weight dosage level 
when administered orally. Calpis sour milk contains IPP and VPP tripeptides which is 
administrated can decrease the systolic blood pressure within 2-4 weeks. ACE inhibitory 
peptides from milk cannot be used as drug for the hypertension treatment but it can be used 
as natural therapeutic agent without side effects. Normally the effect of ACE inhibitory 
peptides from the dairy product is totally depend upon the ability to reach the target site 
without any degradation or any inactivation by the GIT enzyme, peptidases.  So ACEI 
peptides should be resistant to peptidase degradation such as the tripeptides contain C-
terminal prolines are resistant to tryptic peptidases. Beta-lactoglobulin fragment f142-f148 is 
resistant to pepsin and chymotrypsin degradation, which confirms that its ACE inhibitory 
activity will be more. To exert an antihypertensive effect, ACE inhibitory peptides should 
reach the cardiovascular region in an active form. So these peptides should not be damaged 
by human proteases and transported actively through the intestinal wall to the blood. 
Therefore, it is necessary to study the bioavailability of ACEI peptides. 
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                There are several methods developed to measure ACE inhibitory activity, like 
spectrophotometric fluorometric radiochemical, capillary electrophoresis and high-
performance liquid chromatography (HPLC) But HPLC and capillary electrophoresis, 
radiochemical method requires expensive instruments which are not available in all 
laboratories. The most accepted method described by described by Cushman and Cheung is 
spectrophotometric method used for the determination of ACE activity and inhibition in vitro. 
It is based on the hydrolysis of hippuryl-l-histidyl-l-leucine (HHL) by ACE to hippuric acid 
(HA) and histidyl-leucine (HL) as by products. The amount of HA released from HHL is 
directly proportional to the ACE activity. This spectrophotometric method, however, involves 
several tedious steps, these are to extract HA with ethyl acetate, then evaporation, re-
dissolution in water, measure the absorbance of HA at 228 nm, and moreover, ethyl acetate is 
able to extract un-hydrolyzed HHL, which also absorbs strongly at 228 nm, thus 
overestimating the ACE activity. 
                           In this method, the HA concentration from HHL was detected by the action 
of ACE in the presence of ACE inhibitors and antibody synthesis. The peptides may 
stimulate the proliferation and maturation of T cells and natural killer cells for defence of 
new born against a large number of bacteria, particularly enteric bacteria. Also, it has been 
suggested that immune-modulatory milk peptides may alleviate allergic reactions in atopic 
humans and enhance mucosal immunity in the gastrointestinal tract. In this way, immune-
modulatory peptides may regulate the development of the immune system in newborn 
infants. Furthermore, immune-peptides formed during milk fermentation have been shown to 
contribute to the antitumor effects [Matar et al., 2003]. 
                Probiotics are used in production of functional foods, pharmaceutical and 
therapeutic products. The beneficial effects of probiotic micro-organisms appear when they 
arrive in the intestine. The probiotics play important role in digestion and development of the 
gut microflora by modification of the composition  and metabolic activity of the endogenous 
intestinal microbiota  and preventing  the overgrowth and colonization of pathogens by 
stimulating  the immune system  producing anti-bacterial substances (such as bacteriocins 
and hydrogen peroxide), acids (that reduce the pH of the intestine) and competing for 
nutrients. It has been suggested in several studies that some specific changes in gut 
microbiota composition are associated with different diseases [Finegold et al., 2010]. In order 
to produce health effective functional foods, these probiotics should be stored in the viable 
form until consumption and their viability should be maintained throughout GIT since several 
reports suggest that probiotics are poor in surviving environmental changes. So to provide a 
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stable environment, these probiotics are provided with a physical barrier to resist harsh 
environmental condition in GIT, adopting a specific method called as encapsulation.  
                    It is the process involving entrapment of active organisms within a carrier and is 
used to improve living cell count in the functional food, extend their storage life and give 
them a significant form. In other words, it is the method of encapsulating liquid substance 
within solid shell. The goal of this process is to create a micro-environment for the survival 
of bacteria during processing and storage as well as passage through the upper part of the 
GIT. The major application is to protect against low gastric pH and digestive enzymes. The 
outer covering shell is made up of various polymers, carbohydrates, fats and waxes mainly 
dependent on the core material to be protected. Encapsulation technologies can be used in 
many applications in food industry like controlling oxidative reaction, maintaining colours, 
odours, flavours, providing sustained and controlled release and extending shelf life. The 
shell of sealed capsules should be semi-permeable, thin but strong, but it is designed in such a 
way that it releases the probiotic cells in the large intestine. In order to protect bioactive 
compounds such as vitamins, antioxidants, proteins and lipids, several encapsulation 
technologies are used for the production of functional foods with enhanced functionality and 
stability. The best encapsulation technology should be selected for probiotics in order to 
guarantee the survival of bacteria during the encapsulation process, in storage conditions and 
in gut after consumption. 
                             Ionic hydrogel method using sodium alginate is the biopolymer mostly 
used for encapsulation. These are marine polysaccharides naturally occurring as capsular 
polysaccharide in bacteria and these polymer is made up of alginic acid, consisting of a linear 
binary copolymer of α-L-glucuronic acid and C-5 epimer of ß-D-mannuronic acid which are 
bound by 1-4 glycosidic bonds. Probiotic cell is immobilised in alginate due to its rapid, 
versatile and nontoxic nature. When alginate solution dissolves in water, the viscosity as well 
as the length of macromolecules increases. Alginates precipitate by crosslinking, gelling with 
divalent ions like Ca
2+
, Ba
2+
 etc. The gelling occurs when the Ca
2+ 
ions bind in alginate 
giving rise to three dimensional structures. Alginate can easily form gel matrix around 
bacterial cell, it is edible, safe for consumption, cheap, mild temperature needed for their 
function, properly dissolve in intestine and release the entrapped cells. 
                            Generally milk proteins have excellent biocompatibility and are natural 
vehicles for probiotic cells, so they can be used as a delivery system. 
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OBJECTIVES OF THE PROJECT 
The main objectives are 
• To Isolate Lactic acid bacteria (LAB) from Omfed curd, Rourkela. 
• To test for proteolytic activity of the isolates. 
• To determine ACE inhibitory activity by direct spectrophotometric method. 
• To develop watermelon raviolis, a functional food conferring anti-hypertensive effects 
of bioactive peptides formed by fermented milk as well as nutritional values of the 
fruit. 
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MATERIALS AND METHODS 
 
3.1. Isolation of lactic acid bacteria from OMFED curd 
OMFED curd sample was collected and serially diluted up to 10
-7
dilution in each tube 
contained 9 ml of distilled water. 0.1 ml of diluted samples was spread over the surface of 
MRS agar plates (Table 1) and incubated at 37ºC for 48 hours. After incubation, pure cultures 
were prepared and stored in MRS agar slants. Morphology of the isolates was studied by 
gram-staining method.      
Table-1: Composition of MRS agar media 
               Constituents Gram/litre 
proteose peptone 10 
Beef extract 10 
Yeast extract 5 
Dextrose 20 
Polysorbate 80 1 
Ammonium citrate 2 
Sodium acetate 5 
Magnesium sulphate 0.1 
Manganese sulphate 0.05 
Dipotassium phosphate 2 
Agar 12 
Final p
H  
(at 25ºC) 6.5 
 
3.2. Screening for proteolytic activity 
Isolates were streaked on gelatin nutrient agar media (Table 2). Plates were incubated at 30ºC 
for 48 hours. After incubation the plates were flooded with 5 ml mercuric chloride solution 
(15 g of HgCl2 and 20 ml of 6 N HCl in 100 ml distilled water). 
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Tble-2: Composition of gelatine nutrient agar (100ml) 
Constituents Gram / 100 mL 
Gelatin 1. 5  
Glucose 0.1  
Peptone 0.5  
K2HPO4 0.2  
Agar powder 1.5  
                              
3.3 Preparation of hippuric acid calibration curve  
Ten ml of hippuric acid (HA) standard solution was prepared by adding HA (0.4 mg/ml), 
NaCl (300 mM), Sodium borate buffer (100 mM). From this eight solutions having different 
concentrations of hippuric acid ranging from 0.02 mg/ml to 0.16 mg/ml were prepared 
(Table-3). 
 
    Table-3: Concentration of HA sample and SBB solution 
HA sample (mg/ml)  HA stock solution (µl) Sodium borate buffer 
(SBB) (µl) 
0.02 25 475 
0.04 50 450 
0.06 75 425 
0.08 100 400 
0.10 125 375 
0.12 150 350 
0.14 175 325 
0.16 200 300 
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Nine test tubes (5 ml) were taken; one was for blank another 8 for different concentrations of 
hippuric acid. 500 µl of HA, different concentrations in each tube, was taken and 600 µl of 
quinoline were added to each of them followed by vortexing. Then 200 µl of benzene 
sulfonyl chloride (BSC) was added and mixed properly followed by incubation at 30ºC for 30 
min. 3700 µl of ethanol was added and incubated again for 30 min at 30 ºC in dark. Then 
absorbance was measured at 492 nm and the calibration curve was obtained by plotting 
absorbance at 492 nm against HA concentration. 
3.4. ACE inhibitory analysis and protein estimation by nanodrop.  
All the isolates were separately inoculated in MRS broth containing 10% skim milk powder 
and incubated at 37ºC for 48 hours, then centrifuged at 7000 rpm for 20 min  at 5ºC.  Crude 
cell free extracts were collected and protein concentration was estimated using nanodrop. 
ACE inhibitory (ACEI) assay was done by direct spectrophotometric method (table-4) [Le et 
al., 2004]. 
Table -4: ACEI assay protocol 
Components A (captopril,OC1-OC5) B (control) C (blank) 
100 mU/ml ACE (µl) 10 10 10 
1 M HCl  (µl) 0 0 100 
ACEI (sample) (µl) 20 0 20 
Incubate at 37°C for 30 minutes  
5 mM HHL (µl) 50 50 50 
Incubate at 37°C for 30 minutes 
1 M HCl (µl) 100 100 0 
ACEI (sample) (µl)  0 20 0 
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100 mM sodium 
borate buffer (µl) 
320 320 320 
Quinoline (µl) 600 600 600 
BSC (µl 200 200 200 
Incubate at 30°C for 30 minutes in dark  
Ethanol (µl) 3700 3700 3700 
Incubate at 30°C for 30 minutes in dark 
 
ACE cleaves HHL into hippuric acid (HA) and histidyl leucine (HL). For each assay, 
a sample solution of ACE inhibitor (20 µl) and positive test control captopril (20 µl) were 
added to 10 µl of the ACE and incubated for 30 min at 37ºC, then 50 µl of 5 mM HHL in 100 
mM sodium borate buffer (pH 8.3) containing 300mM NaCl was added followed by 
incubation at 37 ºC for 30 min. The reaction was stopped by adding 100 µl of 1 M HCl.  Then 
Sodium borate buffer was added to the reaction mixture to make total volume of 0.5 ml in 
order to maintain the pH. Then 600 µl of quinoline and 200 µl of BSC were added to all the 
tubes followed by incubation at 30ºC for 30 minutes in dark. Finally 3700 µl of ethanol was 
added to all the tubes and incubation was repeated at 30ºC for 30 minutes in dark. Then the 
absorbance was measured at 492nm. The extent of inhibition was then calculated as follows: 
 
ACE inhibitory activity (%) = (B – A)/ (B – C) × 100 
 
3.5. Development of watermelon ravioli 
Overnight cultures of the selected bacteria were grown in MRS broth. Then centrifuged at 
7000 rpm for 20 min at 5ºC and the pellets were re-suspended in sterile distilled water. 1 ml 
of each bacterial suspension was added to 100 ml of pasteurized milk and incubated for 5 
hours. Then equal volume of sodium alginate (3%) was added and the mixture was added 
drop wise into sterile calcium chloride solution (0.5 M) forming beads containing bioactive 
peptides of milk. The beads were washed twice in water and then added to 100 ml sterile 
17 
 
watermelon juice, to which equal volume of sodium alginate (3%) was added. The mixture 
was added spoonful to calcium chloride solution (0.5 M) forming ravioli which were finally 
washed & refrigerated.  
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RESULTS AND DISCUSSION 
1. Isolation of lactic acid bacteria from OMFED curd 
  
                     Fig-2 : OC1                                              Fig-3 : OC2 
 
   
                  Fig-4 : OC3                                        Fig-5 : OC4 
 
                                      
                                                                 Fig -6 : OC5             
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OC1, OC2, OC3, OC4 and OC5 bacterial strains were isolated from OMFED curd, Rourkela 
(figures- 2, 3, 4, 5, 6). 
2. Morphological characterization by gram-staining method  
All the isolated organisms were bacteria. Except OC4 (OMFED CURD 4), all other 
bacterial isolates were gram positive (Table 5). 
 
Table -5: Morphological characterization of isolates 
 
Isolates shape Type of bacteria 
OC1 Long rod Gram positive 
OC2 Long rod Gram positive 
OC3 Long rod Gram positive 
OC4 Long rod Gram negative 
OC5 Long rod Gram positive 
 
 
3. Screening for the proteolytic  activity 
 
 
                         Fig-7 OC1                                          Fig-8 OC2 
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                                   Fig-9 OC3                                            Fig-10 OC4 
                                       
                                              Fig-11 OC5 
The isolated bacteria having proteolytic activity were able to break the protein present in 
gelatine nutrient agar media into peptides depending on their level of activity. After adding 
mercuric chloride the un-hydrolyzed gelatine was found to bind with mercuric chloride, as a 
result clear zones of gelatine hydrolysis were seen. The clearest zone was seen in case of 
OC1 followed by OC5, OC4 and OC3. The least clear zone was seen in OC2 plate. Hence, 
OC1 has highest and OC2 has lowest proteolytic activity while the rest three have 
intermediate activity levels. 
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4. Hippuric acid calibration curve 
Considering the concentrations ranging from 0.02 to 0.16 mg of hippuric acid (HA), the 
standard curve was prepared by plotting absorbance at 492 nm against concentration of HA 
(Fig. 12). 
Fig-12: Hippuric acid (HA) calibration curve showing absorbance at 492 nm 
           
 
5. Protein estimation using nanodrop - 
Control (un-fermented) showed more amount of total protein than the fermented samples 
(table-6). 
Table-6: Estimation of protein concentration by nanodrop 
Sample Concentration (mg/ml) 
control 66 
OC1 45 
OC2 61 
OC3 60 
OC4 50 
OC5 47 
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6. Observation and calculation for ACEI assay  
ACE inhibitory activity was calculated by formula: 
                      ACE inhibitory activity (%) = (B-A) / (B-C) *100 
Where, B=control 
                 A=sample 
                 C= blank 
Isolate OC1 showed highest ACE inhibitory activity as it released less concentration of HA 
by the cleavage of HHL in presence of ACE. Hence less amount of the chromogen complex 
was formed by reaction of HA with quinoline and BSC, thus giving lowest OD. The ACEI 
activity of peptides produced from fermentation by OF3 was even found to be more than that 
of the commercial drug Captopril generally used for the treatment of hypertension. The other 
effective and comparable ACEI inhibitory peptide forming organisms were OF5, OF4 and 
OF3 (table-7). Hence these four organisms were selected for further use. 
Table – 7: ACE inhibitory activity with respect to HA concentration 
Sample OD ACEI 
(%) 
HA concentration 
(mg/ 5ml) 
control 0.071 0 0.0183 
captopril 0.011 84.5 0.0062 
OC1 0.005 93 0.005 
OC2 0.064 10 0.017 
OC3 0.041 42 0.0123 
OC4 0.023 68 0.0087 
OC5 0.017 76 0.0075 
 
7. Development of watermelon ravioli having antihypertensive peptides 
After 5 hours of incubation of the organisms in pasteurised milk, fermented and having 
antihypertensive peptides, encapsulation was carried out giving rise to small beads of the 
fermented milk (fig-13). 
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Fig-13: Fermented Omfed milk encapsulated into beads having antihypertensive 
peptides 
 
                 
 
Sterilised watermelon juice was combined with the prepared beads (fig-14) and after 
another phase of encapsulation into larger forms, the desired product, watermelon 
ravioli was formed (fig-15).    
Fig-14 : watermelon juice combined with beads 
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Fig-15: Watermelon ravioli with antihypertensive bioactive peptides from fermented 
OMFED milk in presence of isolated bacteria. 
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CONCLUSION 
 
Among the isolates, OC1 was found to have highest ACEI activity (93%) while OC5 (76%), 
OC3 (68%) and OC4 (42%) had moderate ACEI activity. OC2 (10%) was found to have least 
ACEI activity. So it can be concluded that in case of OC2 the ACE activity was not inhibited 
by the peptides formed, hence ACE acted on HHL (substrate) giving rise to high 
concentration of  HA and histidyl leucine. The concentration of HA is thereby inversely 
proportional to the ACEI activity of the peptides formed after fermentation with respective 
isolate. The final product, watermelon ravioli has the ACEI activity due to the peptides as 
well as the nutritional quality of the fruit in a much more attractive and palatable form. 
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